Study directory

Schizophrenia studies

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
4306studies shown
Showing 2,185-2,196 of 4,306
Drug study icon
CompletedNCT03669250

CVN058 Effect on Mismatch Negativity in Schizophrenics

This summary needs review. Please check the official study record and contact the research team for details.

In New York
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugA study involving a medication or substance.From 18 Years to 50 Years
Countries
United States
Sponsor
Cerevance Alpha, Inc.
Condition
Schizophrenia
Behavioral study icon
CompletedNCT00963924

D-cycloserine Augmentation of Cognitive Remediation in Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In Boston
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaBehavioralFrom 18 Years to 65 Years
Countries
United States
Sponsor
Massachusetts General Hospital
Condition
Schizophrenia
Drug study icon
CompletedNCT02156908

D-serine and Cognitive Remediation in Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In Orangeburg
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 64 Years
Countries
United States
Sponsor
Nathan Kline Institute for Psychiatric Research
Condition
Schizophrenia
Drug study icon
SuspendedNCT05046353

D-serine AudRem: R33 Phase

This summary needs review. Please check the official study record and contact the research team for details.

In New York
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 50 Years
Countries
United States
Sponsor
New York State Psychiatric Institute
Condition
Schizophrenia
Drug study icon
CompletedNCT03711500

D-serine Augmentation of Neuroplasticity

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including New York
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 50 Years
Countries
United States
Sponsor
New York State Psychiatric Institute
Condition
Schizophrenia
Drug study icon
CompletedNCT00826202

D-serine for the Schizophrenia Prodrome

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including New Haven
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 13 Years to 35 Years
Countries
United States
Sponsor
Nathan Kline Institute for Psychiatric Research
Condition
Schizophrenia
Drug study icon
CompletedNCT00816894

D-serine Monotherapy for Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In Jerusalem
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 70 Years
Countries
Israel
Sponsor
Herzog Hospital
Condition
Schizophrenia
Drug study icon
CompletedNCT01390376

DAAOI-1 Treatment for Treatment-resistant Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In Taichung
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 65 Years
Countries
Taiwan
Sponsor
China Medical University Hospital
Condition
Schizophrenia
Drug study icon
CompletedNCT02532686

DAAOI-2 add-on Treatment for Treatment-resistant Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In Taichung
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 65 Years
Countries
Taiwan
Sponsor
China Medical University Hospital
Condition
Schizophrenia
Drug study icon
TerminatedNCT01712646

Daily Intranasal Oxytocin for Childhood-Onset Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In Bethesda
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 10 Years to 99 Years
Countries
United States
Sponsor
National Institute of Mental Health (NIMH)
Condition
Schizophrenia
Drug study icon
CompletedNCT01041274

DECIFER: Depression and Citalopram In First Episode Recovery

This summary needs review. Please check the official study record and contact the research team for details.

In New York
Why is this study shown?

This study is directly about Schizophrenia.

Schizophrenia, DepressionDrugFrom 16 Years to 40 Years
Countries
United States
Sponsor
NYU Langone Health
Condition
Schizophrenia, Depression
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.